Click to view full size
Description
Saxagliptin (rINN) is an orally active hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. FDA approved on July 31, 2009.
From NIH 3D
Model source and downloads
This page preserves searchable metadata and attribution. Use NIH 3D for the current files and source details.
- Source creator
- James Tyrwhitt Drake
- Source license
- Public Domain
Archived copies are shared under the license shown.
View/download on NIH 3DTags
Makes
See how others have printed this model
(1S,3S,5S)-2-[(2S)-2-amino-2-[(5R)-3-hydroxy-1-adamantyl]acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
From NIH 3D
Likes
0Views
0Remixes
0